Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
AMLX
AMLX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AMLX News
Amylyx Pharmaceuticals: 2026 Could Be Transformative Ahead of Avexitide Phase 3 Readout
6d ago
Yahoo Finance
Amylyx Pharmaceuticals Q4 2025 Earnings Call Insights
6d ago
seekingalpha
Amylyx (AMLX) Q4 2025 Earnings Call Transcript
6d ago
NASDAQ.COM
Amylyx Pharmaceuticals Q4 2025 Earnings Beat Expectations
Mar 03 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Mar 03 2026
Benzinga
Amylyx Pharmaceuticals to Announce Q4 Earnings on March 3
Mar 02 2026
seekingalpha
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
Feb 26 2026
Newsfilter
Joshua B Cohen Sells 138,167 Shares for $1.9 Million
Feb 01 2026
NASDAQ.COM
Amylyx Pharmaceuticals CEO Executes Significant Stock Sale Amid Ongoing Investigation
Feb 01 2026
Fool
Investigation into Amylyx Pharmaceuticals' Corporate Governance Breaches
Jan 29 2026
PRnewswire
AMLX Options Contract Analysis and Investment Opportunities
Jan 27 2026
NASDAQ.COM
Amylyx Pharmaceuticals (AMLX) Hits New 52-Week High with Over 50% Gain
Jan 22 2026
NASDAQ.COM
AMLX Options Analysis: Put Contract Yield Boost of 6.15%
Jan 16 2026
NASDAQ.COM
Amylyx Pharmaceuticals (AMLX) Hits Oversold RSI of 29.0 Amid Heavy Selling
Jan 05 2026
NASDAQ.COM
Amylyx and MAIA Executives Increase Stock Holdings Amid Market Fluctuations
Dec 26 2025
NASDAQ.COM
Post-Market Winners: A Calm Trading Day Highlighted by a Notable Biotech Rise
Dec 17 2025
NASDAQ.COM
Show More News
